We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QXO
6601
QXO Inc
QXO
$17.4B
$0 ﹤0.01%
14
-206
-94% -$4.47K
ONIT
6602
Onity Group
ONIT
$332M
$0 ﹤0.01%
10
-824
-99% -$19.4K
BVC
6603
BitVentures Limited Ordinary Shares
BVC
$2.11B
– –
-865
Closed -$6K
FLD
6604
Fold Holdings
FLD
$24.9M
– –
-30
Closed –
BSLK
6605
DELISTED
Bolt Projects Holdings
BSLK
$0 ﹤0.01%
1
– –
ORKA
6606
Oruka Therapeutics
ORKA
$5.96B
– –
-413
Closed -$11K
GRCE
6607
Grace Therapeutics
GRCE
$34.7M
– –
-102
Closed -$1K
PVLA
6608
Palvella Therapeutics
PVLA
$2.27B
$0 ﹤0.01%
3
-7
-70% -$1.28K
JXG
6609
JX Luxventure
JXG
$96M
– –
-7
Closed -$8.75K
OUSTZ
6610
DELISTED
Ouster Inc Warrants
OUSTZ
$0 ﹤0.01%
107
+7
+7% +$4
XIFR
6611
XPLR Infrastructure LP
XIFR
$1.08B
– –
-29
Closed -$2K
CYCU
6612
Cycurion Inc
CYCU
$7.01M
$0 ﹤0.01%
+1
New +$295
EVBN
6613
DELISTED
Evans Bancorp Inc
EVBN
– –
-19
Closed -$1K
PEV
6614
DELISTED
Phoenix Motor Inc. Common Stock
PEV
$0 ﹤0.01%
+34
New +$148
GATEU
6615
DELISTED
Marblegate Acquisition Corp. Unit
GATEU
– –
-150
Closed -$1K
ACHL
6616
DELISTED
Achilles Therapeutics
ACHL
$0 ﹤0.01%
21
– –
BCOW
6617
DELISTED
1895 Bancorp of Wisconsin
BCOW
– –
-56
Closed -$1K
HCP
6618
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
– –
-4,821
Closed -$260K
PWUPU
6619
DELISTED
PowerUp Acquisition Corp. Unit
PWUPU
– –
-2,760
Closed -$28K
BYNO
6620
DELISTED
byNordic Acquisition Corporation Class A Common Stock
BYNO
$0 ﹤0.01%
+45
New +$447
BYNOU
6621
DELISTED
byNordic Acquisition Corporation Units
BYNOU
– –
-969
Closed -$10K
RFAC
6622
DELISTED
RF Acquisition Corp. Class A Common Stock
RFAC
$0 ﹤0.01%
+24
New +$236
RFACU
6623
DELISTED
RF Acquisition Corp. Unit
RFACU
$0 ﹤0.01%
41
-249
-86% -$2.5K
EVGRU
6624
DELISTED
Evergreen Corporation Unit
EVGRU
$0 ﹤0.01%
33
– –
INSI
6625
DELISTED
Insight Select Income Fund
INSI
$0 ﹤0.01%
+27
New +$450
263 264
265
266 267

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.